{"id":995,"date":"2016-08-17T17:56:21","date_gmt":"2016-08-17T12:26:21","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=995"},"modified":"2023-06-14T17:25:41","modified_gmt":"2023-06-14T11:55:41","slug":"snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer","title":{"rendered":"Collaboration provides new insight into cancer treatment"},"content":{"rendered":"

Some collaborations change the face of treatment scenario, and this collaboration is one example of that. An immunologist collaborated with an oncologist to help fight the immunologist\u2019s stepmother fight cancer, and turned the face of transformative therapy. The discovery is of a new class of drugs that help in bypassing a molecular break that stops the immune system from attacking tumors. The main problem in cancer is that patients immunotherapy doesn\u2019t always work. Here, the researchers identified a unique type of immune-system cell that helps in predicting whether patients will respond to one of the medicines or not\u2014significantly sorting out patients that can positively benefit from the therapy. This discovery is based on the analysis of 40 patients, whose cancer is treated with Keytruda, a checkpoint inhibitor from Merck & Co., which targets an immune-system brake called PD-1.<\/p>\n","protected":false},"excerpt":{"rendered":"

Some collaborations change the face of treatment scenario, and this collaboration is one example of that. An immunologist collaborated with an oncologist to help fight the immunologist\u2019s stepmother fight cancer, and turned the face of transformative therapy. The discovery is of a new class of drugs that help in bypassing a molecular break that stops […]<\/p>\n","protected":false},"author":1,"featured_media":997,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[41],"tags":[137,17271,810,315],"industry":[17225],"therapeutic_areas":[17228],"class_list":["post-995","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-snippets","tag-cancer","tag-car-t-immunotherapy","tag-car-t","tag-immunotherapy","industry-pharmaceutical","therapeutic_areas-oncology"],"acf":[],"yoast_head":"\nCollaborative Approach in Cancer Treatment | Cancer Research<\/title>\n<meta name=\"description\" content=\"The discovery is of a new class of drugs that help in bypassing a molecular break that stops the immune system from attacking tumors...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Collaborative Approach in Cancer Treatment | Cancer Research\" \/>\n<meta property=\"og:description\" content=\"The discovery is of a new class of drugs that help in bypassing a molecular break that stops the immune system from attacking tumors...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-17T12:26:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-14T11:55:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/08\/09021230\/shutterstock_249483448-1-890x400.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"890\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Collaborative Approach in Cancer Treatment | Cancer Research","description":"The discovery is of a new class of drugs that help in bypassing a molecular break that stops the immune system from attacking tumors...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer","og_locale":"en_US","og_type":"article","og_title":"Collaborative Approach in Cancer Treatment | Cancer Research","og_description":"The discovery is of a new class of drugs that help in bypassing a molecular break that stops the immune system from attacking tumors...","og_url":"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2016-08-17T12:26:21+00:00","article_modified_time":"2023-06-14T11:55:41+00:00","og_image":[{"width":890,"height":400,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/08\/09021230\/shutterstock_249483448-1-890x400.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer","url":"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer","name":"Collaborative Approach in Cancer Treatment | Cancer Research","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/08\/09021230\/shutterstock_249483448-1-890x400.jpg","datePublished":"2016-08-17T12:26:21+00:00","dateModified":"2023-06-14T11:55:41+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"The discovery is of a new class of drugs that help in bypassing a molecular break that stops the immune system from attacking tumors...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/snippets-a-chance-collaboration-provides-new-insight-on-treatment-of-cancer#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/08\/09021230\/shutterstock_249483448-1-890x400.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/08\/09021230\/shutterstock_249483448-1-890x400.jpg","width":890,"height":400},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/08\/09021230\/shutterstock_249483448-1-890x400-300x135.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">CAR T Immunotherapy<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">CAR-T<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Immunotherapy<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Cancer<\/span>","<span class=\"advgb-post-tax-term\">CAR T Immunotherapy<\/span>","<span class=\"advgb-post-tax-term\">CAR-T<\/span>","<span class=\"advgb-post-tax-term\">Immunotherapy<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 10 years ago","modified":"Updated 3 years ago"},"absolute_dates":{"created":"Posted on Aug 17, 2016","modified":"Updated on Jun 14, 2023"},"absolute_dates_time":{"created":"Posted on Aug 17, 2016 5:56 pm","modified":"Updated on Jun 14, 2023 5:25 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=995"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/995\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/997"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=995"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=995"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}